SLIDE 1
- Safeguarding the Child Athlete?
- Potential types of ‘violence’ which threaten our athletes
- RED-S
- Supplements
- Doping
- Questions
Sports in Children: Medical and Ethical dilemmas Dr Leigh Gordon - - PowerPoint PPT Presentation
Sports in Children: Medical and Ethical dilemmas Dr Leigh Gordon - - PowerPoint PPT Presentation
GP Paediatric update 2017 Sports in Children: Medical and Ethical dilemmas Dr Leigh Gordon Sports & Exercise Medicine Physician Outline Safeguarding the Child Athlete? Potential types of violence which threaten our athletes
SLIDE 2
SLIDE 3
IOC Consensus statement: Youth athlete development model for safeguarding the child athlete
(Bergeron MF
, Mountjoy M, Armstrong N, et al. Br J Sports Med 2015;49:843– 851.)
1) IOC Olympic Charter (2013) 2) IOC Olympic Movement medical code (2009)
all stakeholders “should take care that sport is practiced without danger to the health of the athletes and with respect for fair play and sports ethics … [and should take] measures necessary to protect the health of participants and to minimize the risks of physical injury and psychological harm.” Mountjoy M, Rhind DJA, Tiivas A, et al. Br J Sports Med 2015;49:883–886.
SLIDE 4
Mountjoy M, Rhind DJA, Tiivas A, et al. Br J Sports Med 2015;49:883–886.
SLIDE 5
Relative Energy Deficiency in Sport
with or without disordered eating (DE) or eating disorders (ED) The syndrome of RED-S refers to impaired physiological function including, but not limited to, metabolic rate, menstrual function, bone health, immunity, protein synthesis, cardiovascular health caused by relative energy deficiency. Prevalence of EDs in adolescent sport
RED-S
SLIDE 6
Health Consequences of RED-S
Mountjoy M, Sundgot-Borgen J, Burke L, et al. Br J Sports Med 2014;48:491–497.
SLIDE 7
Why are they used?
- Increase muscle mass
- ? Increase performance
- Targeted marketing
Supplements
SLIDE 8
Maybe…
Supplements: do they work?
SLIDE 9
Are they safe?
Supplements
SLIDE 10
Not regulated… (don’t have to prove safety / efficacy) Ingredients do not have to declare everything Risk of contamination Not everything herbal is safe…
Supplements
SLIDE 11
How to mitigate your risk…
Supplements
SLIDE 12
Supplements
SLIDE 13
Anti-Doping: WADA
SLIDE 14
Anti-Doping: WADA
Prohib
- hibited
ited Su Substances stances
ANABOLIC BOLIC AGENT ENTS AAS AAS Other r anab abolic
- lic agents
ts eg eg tib ibolo lone ne and d cle lenbu buterol terol PEPTIDE TIDE HO HORMONES ONES, , GROWTH OWTH FACT CTORS ORS, , RELATE TED D SUBSTANCES ANCES, , AND MIMET ETICS ICS Incl Epo po-stim stimulati lating g agents, nts, GH BE BETA-2 2 AGONIS ONISTS TS NB inh B inhale led d sa salb lbutamo utamol l / fo / formote moterol rol / s / salm lmeterol eterol HO HORMONE ONE AND METAB ABOLIC OLIC MODULA DULATORS ORS DIURET RETICS ICS AND MASKI KING NG AGENT ENTS
MANIPULATION OF BLOOD AND BLOOD COMPONENTS CHEMICAL AND PHYSICAL MANIPULATION GENE DOPING
SLIDE 15
Anti-Doping: WADA
Prohib
- hibited
ited In Comp mpetition etition
STI TIMULANTS MULANTS (sp speci ecifi fied ed or no non-speci specifi fied) ed) NB: Methy hylph lphenidate enidate – Rit itali lin n / / Concer ncerta ta NARCO COTICS TICS CANNAB NABINOIDS INOIDS GLUCOC UCOCORT ORTICOIDS ICOIDS (All glucocorticoids are prohibited when administered by oral, intravenous, intramuscular, or rectal routes)
PARTICULAR RTICULAR SP SPORT ORTS: : Alc
lcoho
- hol
l / Beta ta blo lockers ers
SLIDE 16
Anti-Doping: WADA
SLIDE 17
Anti-Doping: WADA
AAS S – how common mmon are e they ey in our r scho hools?
- ls?
SA SAID IDS S / S / SARU U have e NO j O jurisdict risdiction ion over er scho hoolboy
- lboy rugby
gby On Only y yo youth th wee eeks ks and U1 U19 9 Curri rrie e cup Data a from m SA SAIDS DS school hools s pilot lot study udy 20 2015 15 (23 23%: : 12 12/5 /52) 2) 2011 2011-201 2016: 6: 62 % 62 % increase crease in ADRV RV (21+ 21+ in 201 2016); 6); 48 48% junior nior rugby gby players yers
SLIDE 18
Anti-Doping: WADA
“Gym, Shake & Spuit”
SLIDE 19
Adverse effects of AAS
(eg eg stanaz anazol
- l /
/ Nandrol drolone
- ne):
): St Stunted nted gr growth,
- wth, acne
Traits its of op
- pposite
- site ge
gender: er: gy gynaecomast ecomastia/smaller ia/smaller tes estes/voice tes/voice In Incre creased ased agg ggression ression Raised ised BP / / cholesterol
- lesterol
Liver ver toxic xicity ity Psychosis ychosis / / Sz Szp Dizziness, ziness, chest est pain n and SC SCA NB Biogen gen Tes estoF toForte
- rte
SLIDE 20
Adverse effects of other substances
- Peptide H (incl GF): EP
EPO - ↑ blood viscosity/ MI
- HgH: allergic rx / diabetogenic, acromegaly
- IGF-1: acromegaly / organomegaly / hypoglycaemia
- Insulin (anabolic): Hypoglycaemia
- B2 agonists: tachycardia, tremor, palps
- HCG: gynaecomastia
SLIDE 21